{"id":236691,"date":"2025-10-24T04:17:22","date_gmt":"2025-10-24T04:17:22","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/236691\/"},"modified":"2025-10-24T04:17:22","modified_gmt":"2025-10-24T04:17:22","slug":"novo-lilly-fall-after-trump-says-the-fat-loss-drug-will-go-down-in-price","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/236691\/","title":{"rendered":"Novo, Lilly fall after Trump says \u201cthe fat loss drug\u201d will go down in price"},"content":{"rendered":"<p><a class=\"css-g65o95\" href=\"https:\/\/sherwood.news\/markets\/super-micro-slumps-after-announcing-preliminary-q1-net-sales-far-below-wall\/\" rel=\"nofollow noopener\" target=\"_blank\">Super Micro slumps after announcing preliminary Q1 net sales far below Wall Street\u2019s expectations<\/a><\/p>\n<p class=\"css-14ve0pc\"><a class=\"inline-stock css-1iix00n\" href=\"https:\/\/robinhood.com\/us\/en\/stocks\/SMCI\/?source=sherwood\" rel=\"nofollow noopener\" target=\"_blank\">Super Micro Computer<\/a> is slumping after management <a href=\"https:\/\/ir.supermicro.com\/news\/news-details\/2025\/Supermicro-Provides-First-Quarter-of-Fiscal-Year-2026-Business-Update\/default.aspx\" target=\"_blank\" class=\"css-uubm0\" rel=\"noopener nofollow\">delivered<\/a> a preliminary revenue update that came in far short of what the Street was expecting.<\/p>\n<p class=\"css-14ve0pc\">Net sales for the quarter ended September 30 (the company\u2019s fiscal Q1 2026) will be about $5 billion, according to a press release, which is below its guidance for $6 billion to $7 billion and below the average analyst estimate of just short of $6.5 billion.<\/p>\n<p class=\"css-14ve0pc\">Management attributed this to \u201crecent design wins in excess of $12 billion, requesting delivery in the second quarter of fiscal year 2026 (Q2\u201926).\u201d<\/p>\n<p class=\"css-14ve0pc\">Charles Liang, President and CEO reitereated the company\u2019s expectation of $33 billion in revenues for the fiscal year that started in July, saying \u201cWe see customer demand accelerating, and we are gaining AI share.\u201d<\/p>\n<p class=\"css-14ve0pc\">If net sales do come in around $5 billion, that would be a roughly 20% decline versus the same period in 2024.<\/p>\n<p class=\"css-14ve0pc\">This is not the first time this year that Super Micro has preannounced a revenue miss and effectively blamed it on timing issues.<\/p>\n<p class=\"css-14ve0pc\">On April 29, the company <a href=\"https:\/\/sherwood.news\/markets\/super-micros-massive-sales-miss-is-the-latest-headache-for-the-volatile-ai\/\" target=\"_blank\" class=\"css-uubm0\" rel=\"noopener nofollow\">preannounced disappointing results<\/a> and said, \u201cDuring Q3 some delayed customer platform decisions moved sales into Q4.\u201d Pushing back the timing of a big revenue ramp has <a href=\"https:\/\/sherwood.news\/markets\/investors-have-run-out-of-patience-with-super-micros-many-excuses-for-sales\/\" target=\"_blank\" class=\"css-uubm0\" rel=\"noopener nofollow\">been a common theme for Super Micro throughout the year<\/a>.<\/p>\n<p class=\"css-14ve0pc\">As we wrote in August:<\/p>\n<p class=\"css-14ve0pc\">\u201cIf I could boil down the cause of the substantial volatility in shares of Super Micro Computer this year to one sentence, it would be this: it\u2019s in the AI business \u2014 which is clearly booming \u2014 and management makes big promises on sales that it fails to deliver on.<\/p>\n<p>Sales are the football, management is Lucy, and investors are Charlie Brown, falling for each renewed promise and then having it yanked away and landing flat on their backs.\u201d<\/p>\n<p class=\"css-14ve0pc\">Super Micro scheduled an earnings call for Nov. 4 to discuss the outlook for second-quarter revenues and deliveries.<\/p>\n","protected":false},"excerpt":{"rendered":"Super Micro slumps after announcing preliminary Q1 net sales far below Wall Street\u2019s expectations Super Micro Computer is&hellip;\n","protected":false},"author":2,"featured_media":236692,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490],"class_list":{"0":"post-236691","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/236691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=236691"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/236691\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/236692"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=236691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=236691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=236691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}